PLX
#3639
Protalix BioTherapeutics, Inc. Common Stock
2.3 7 USD
+0.03%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
+2.60%
Monatliche Änderung
+2.16%
6 month change
-18.84%
Jahresänderung
-18.84%
Vorheriger Schlusskurs
2.3 1
Open
2.3 6
Tief
2.3 5
High
2.3 9
Volumen
176
Financials
2012
Current report, Q4 FY2012
Protalix Biotherapeutics, Inc. current report, Q4 FY2012
8-K
Current report, Q4 FY2012
Protalix Biotherapeutics, Inc. current report, Q4 FY2012
8-K
Current report, Q4 FY2012
Protalix Biotherapeutics, Inc. current report, Q4 FY2012
8-K
Current report, Q3 FY2012
Protalix Biotherapeutics, Inc. current report, Q3 FY2012
8-K
Current report, Q3 FY2012
Protalix Biotherapeutics, Inc. current report, Q3 FY2012
8-K
Current report, Q3 FY2012
Protalix Biotherapeutics, Inc. current report, Q3 FY2012
8-K
Current report, Q3 FY2012
Protalix Biotherapeutics, Inc. current report, Q3 FY2012
8-K
Current report, Q3 FY2012
Protalix Biotherapeutics, Inc. current report, Q3 FY2012
8-K
Current report, Q2 FY2012
Protalix Biotherapeutics, Inc. current report, Q2 FY2012
8-K
Current report, Q2 FY2012
Protalix Biotherapeutics, Inc. current report, Q2 FY2012
8-K